Long-term effects after treatment with platinum compounds, cisplatin and [Pt(O,O′-acac)(γ-acac)(DMS)]: Autophagy activation in rat B50 neuroblastoma cells

• Published in: Toxicology and applied pharmacology 2019-02, Vol.364, p.1-11
• Main Authors: Grimaldi, Maddalena, Bo, Veronica Dal, Ferrari, Beatrice, Roda, Elisa, De Luca, Fabrizio, Veneroni, Paola, Barni, Sergio, Verri, Manuela, De Pascali, Sandra A., Fanizzi, Francesco P., Bernocchi, Graziella, Bottone, Maria G.
• Format: Article
• Language: English
• Subjects: Apoptosis; Autophagy; CisPt; Drug-resistance; Neuroblastoma rat cells; PtAcacDMS
• ISSN: 0041-008X; 1096-0333
• DOI: 10.1016/j.taap.2018.12.005

Cisplatin (cisPt), among the best known components of multi-drug front-line therapies used for the treatments of solid tumors, such as the childhood neuroblastoma, acts through DNA linking. Nevertheless, the cisPt effectiveness is compromised by the onset of severe side effects, including neurotoxicity that results in neurodegeneration, cell death, and drug-resistance. In the field of experimental oncology, aimed at overcoming cytotoxicity and chemoresistance, great efforts are devoted to the synthesis of new platinum-based drugs, such as [Pt(O,O′-acac)(γ-acac)(DMS)] (PtAcacDMS), which shows a specific reactivity with sulfur residues of enzymes involved in apoptosis. Autophagy, an evolutionary conserved degradation pathway for recycling of cytoplasmic components, represents one of the mechanisms adopted by cancer cells which contribute to drug-resistance. In the present study, standard acute (48 h-exposure) and long-term effects (7 day-recovery after treatment or 7 day-recovery followed by reseeding and 96 h-growth), of cisPt and PtAcacDMS (40 and 10 μM, respectively) were investigated in vitro employing rat B50 neuroblastoma as a cancer model. Using fluorescence and electron microscopy, as well as biochemical techniques, our data highlight a key role of the autophagic process in B50 cells. Specifically, long-term effects caused by cisPt lead to inhibition of the apoptotic process and paralleled by the activation of autophagy, thus evidencing that autophagy has a protective role after cisPt exposure, allowing cells to survive. Whereas, long-term effects produced by PtAcacDMS lead toward both apoptosis and autophagy activation. In conclusion, autophagy may represents an alternative cell death pathway, circumventing drug-resistance strategies employed by cancer cells to survive chemoterapy. •Clinical use of cisPt limited by CNS severe side effects and drug-resistance•Synthesis of new PtAcacDMS to overcome cytotoxicity and chemoresistance•Autophagy role in B50 neuroblastoma cells after cisPt- and PtAcacDMS-exposure•PtAcacDMS as an alternative molecule in the treatment of cancer